Immunocore Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	2,907	3,378	2,734	1,500	-	-	-
Market Cap Growth	-	23.54%	82.31%	-	-	-	-
Enterprise Value	2,459	3,019	2,413	1,282	-82	-18	-132
PE Ratio	-61.09	-61.09	-52.03	-8.33	-	-	-
PS Ratio	11.65	13.54	15.68	41.10	-	-	-
PB Ratio	6.31	9.16	8.07	6.99	-	-	-
P/FCF Ratio	-1359.20	-1359.20	-53.18	-10.39	-	-	-
P/OCF Ratio	791.96	1148.85	-55.56	-10.48	-	-	-
EV/Sales Ratio	9.86	12.10	13.84	35.14	-2.19	-0.57	-4.46
EV/EBITDA Ratio	-60.38	-60.38	-85.98	-7.79	0.88	0.14	1.31
EV/EBIT Ratio	-54.17	-54.17	-68.02	-7.35	0.78	0.12	1.21
EV/FCF Ratio	-1214.90	-1214.90	-46.94	-8.88	0.63	0.12	5.07
Debt / Equity Ratio	0.23	0.23	0.24	0.37	1.15	4.02	0.33
Debt / EBITDA Ratio	-1.68	-1.68	-2.90	-0.48	-0.85	-0.55	-0.23
Debt / FCF Ratio	-33.82	-33.82	-1.58	-0.55	-0.61	-0.49	-0.91
Quick Ratio	3.56	3.56	4.32	4.14	2.55	0.99	2.78
Current Ratio	3.80	3.80	4.70	4.29	2.78	1.47	3.45
Asset Turnover	0.44	0.44	0.39	0.09	0.16	0.14	-
Interest Coverage	-10.81	-10.81	-6.56	-31.28	-24.88	-12.45	-103.72
Return on Equity (ROE)	-15.50%	-15.50%	-18.80%	-68.50%	-211.30%	-291.30%	-
Return on Assets (ROA)	-9.80%	-9.80%	-11.60%	-42.20%	-38.70%	-54.50%	-
Return on Capital (ROIC)	-13.17%	-13.17%	-12.30%	-59.34%	-72.29%	-159.51%	-123.85%
Earnings Yield	-1.90%	-1.64%	-1.92%	-12.01%	-	-	-
FCF Yield	-0.11%	-0.07%	-1.88%	-9.63%	-	-	-
Buyback Yield / Dilution	-6.94%	-6.94%	-7.59%	-4.29%	-	-	-
Total Shareholder Return	-6.94%	-6.94%	-7.59%	-4.29%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).